FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891619191> ?p ?o ?g. }

• W2891619191 endingPage "332" @default.
• W2891619191 startingPage "324" @default.
• W2891619191 abstract "1) Revisar sistemática y críticamente la evidencia sobre eficacia y seguridad de la terapia combinada con fármacos modificadores de la enfermedad (FAME) sintéticos en la artritis reumatoide (AR); 2) Emitir recomendaciones prácticas sobre su uso. Se realizó una revisión sistemática de la literatura con una estrategia de búsqueda bibliográfica sensible en Medline, Embase y Cochrane Library. Se seleccionaron ensayos clínicos aleatorizados que analizasen la eficacia y/o seguridad de 1) la terapia combinada con FAME sintéticos comparada con la terapia secuencial con FAME sintético en la AR de inicio; y 2) la combinación metotrexato + leflunomida o la triple terapia de FAME sintéticos en la AR establecida refractaria a FAME sintéticos. Dos revisores realizaron la primera selección por título y abstract y 11 la selección tras lectura en detalle y la recogida de datos. La calidad se evaluó con la escala de Jadad. En una reunión de grupo nominal en base sus resultados se consensuaron una serie de recomendaciones. Finalmente no se incluyó ningún artículo en la RSL. Del análisis de los artículos revisados se encontró la eficacia en las AR de inicio del tratamiento precoz con FAME sintéticos siguiendo una estrategia «treat to target» y en AR establecidas refractarias a FAME sintéticos la de la terapia combinada con FAME sintéticos. Con ello se generaron 5 recomendaciones sobre la terapia combinada con FAME sintéticos. Estas recomendaciones pretenden facilitar la toma de decisiones con el uso de la terapia combinada con FAME sintéticos en la AR. 1) To systematically and critically review the evidence of combined therapy with synthetic disease-modifying antirheumatic drugs (DMARD) in rheumatoid arthritis (RA); 2) To design practical recommendations on their use. A systematic literature review (SLR) was performed with a sensitive bibliographic search strategy in Medline, EMBASE and Cochrane Library. We selected randomized clinical trials that analyzed the efficacy and/or safety of 1) combined therapy of synthetic compared with sequential therapy of synthetic DMARD in early RA; and 2) combination of methotrexate + leflunomide or triple therapy with synthetic DMARD in established RA refractory to synthetic DMARD. Two reviewers made the first selection by title and abstract and 11 performed the selection after detailed review of the articles and data collection. The quality of the studies was evaluated with the Jadad scale. Based on the results, related recommendations were agreed upon in a nominal group meeting. Ultimately, no articles were included in the SLR. The analysis of the reviewed articles demonstrated the effectiveness of the treatment with synthetic DMARD following a “treat to target” strategy in early RA patients, and of combination therapy of synthetic DMARD in established RA refractory to synthetic DMARD. This resulted in 6 recommendations concerning combination therapy with synthetic DMARD. These recommendations aim to facilitate decision-making with the use of combined therapy with DMARD in RA." @default.
• W2891619191 created "2018-09-27" @default.
• W2891619191 creator A5002957542 @default.
• W2891619191 creator A5011863380 @default.
• W2891619191 creator A5012088085 @default.
• W2891619191 creator A5012535623 @default.
• W2891619191 creator A5021833323 @default.
• W2891619191 creator A5024989796 @default.
• W2891619191 creator A5028935094 @default.
• W2891619191 creator A5029767844 @default.
• W2891619191 creator A5041596944 @default.
• W2891619191 creator A5043290779 @default.
• W2891619191 creator A5050109776 @default.
• W2891619191 creator A5064453636 @default.
• W2891619191 creator A5090968141 @default.
• W2891619191 date "2020-09-01" @default.
• W2891619191 modified "2023-09-26" @default.
• W2891619191 title "Eficacia y seguridad de la terapia combinada con fármacos modificadores de la enfermedad sintéticos en la artritis reumatoide: revisión sistemática de la literatura" @default.
• W2891619191 cites W1594638363 @default.
• W2891619191 cites W1918195983 @default.
• W2891619191 cites W1986215651 @default.
• W2891619191 cites W1988848155 @default.
• W2891619191 cites W2024493032 @default.
• W2891619191 cites W2033885007 @default.
• W2891619191 cites W2100753300 @default.
• W2891619191 cites W2115498627 @default.
• W2891619191 cites W2120393706 @default.
• W2891619191 cites W2124066744 @default.
• W2891619191 cites W2143218813 @default.
• W2891619191 cites W2145807352 @default.
• W2891619191 cites W2155109530 @default.
• W2891619191 cites W2156712409 @default.
• W2891619191 cites W2156996668 @default.
• W2891619191 cites W2161249330 @default.
• W2891619191 cites W2183749246 @default.
• W2891619191 cites W2313344922 @default.
• W2891619191 cites W2320562573 @default.
• W2891619191 cites W2346045392 @default.
• W2891619191 cites W2549510815 @default.
• W2891619191 cites W2570964461 @default.
• W2891619191 cites W2600405003 @default.
• W2891619191 cites W2605174003 @default.
• W2891619191 cites W2738512418 @default.
• W2891619191 cites W2786235520 @default.
• W2891619191 cites W4210768724 @default.
• W2891619191 doi "https://doi.org/10.1016/j.reuma.2018.07.016" @default.
• W2891619191 hasPublicationYear "2020" @default.
• W2891619191 type Work @default.
• W2891619191 sameAs 2891619191 @default.
• W2891619191 citedByCount "2" @default.
• W2891619191 countsByYear W28916191912020 @default.
• W2891619191 countsByYear W28916191912022 @default.
• W2891619191 crossrefType "journal-article" @default.
• W2891619191 hasAuthorship W2891619191A5002957542 @default.
• W2891619191 hasAuthorship W2891619191A5011863380 @default.
• W2891619191 hasAuthorship W2891619191A5012088085 @default.
• W2891619191 hasAuthorship W2891619191A5012535623 @default.
• W2891619191 hasAuthorship W2891619191A5021833323 @default.
• W2891619191 hasAuthorship W2891619191A5024989796 @default.
• W2891619191 hasAuthorship W2891619191A5028935094 @default.
• W2891619191 hasAuthorship W2891619191A5029767844 @default.
• W2891619191 hasAuthorship W2891619191A5041596944 @default.
• W2891619191 hasAuthorship W2891619191A5043290779 @default.
• W2891619191 hasAuthorship W2891619191A5050109776 @default.
• W2891619191 hasAuthorship W2891619191A5064453636 @default.
• W2891619191 hasAuthorship W2891619191A5090968141 @default.
• W2891619191 hasConcept C138885662 @default.
• W2891619191 hasConcept C15708023 @default.
• W2891619191 hasConcept C71924100 @default.
• W2891619191 hasConceptScore W2891619191C138885662 @default.
• W2891619191 hasConceptScore W2891619191C15708023 @default.
• W2891619191 hasConceptScore W2891619191C71924100 @default.
• W2891619191 hasIssue "5" @default.
• W2891619191 hasLocation W28916191911 @default.
• W2891619191 hasOpenAccess W2891619191 @default.
• W2891619191 hasPrimaryLocation W28916191911 @default.
• W2891619191 hasRelatedWork W2473335724 @default.
• W2891619191 hasRelatedWork W2609344916 @default.
• W2891619191 hasRelatedWork W2748952813 @default.
• W2891619191 hasRelatedWork W2780307509 @default.
• W2891619191 hasRelatedWork W2899084033 @default.
• W2891619191 hasRelatedWork W4210390885 @default.
• W2891619191 hasRelatedWork W59019880 @default.
• W2891619191 hasRelatedWork W766819059 @default.
• W2891619191 hasRelatedWork W2308060692 @default.
• W2891619191 hasRelatedWork W2478882070 @default.
• W2891619191 hasVolume "16" @default.
• W2891619191 isParatext "false" @default.
• W2891619191 isRetracted "false" @default.
• W2891619191 magId "2891619191" @default.
• W2891619191 workType "article" @default.